Carboxymethyl dextran-cyclodextrin conjugate as the carrier of doxorubicin

Journal of Nanoscience and Nanotechnology

Volumn 13, Issue 11, 2013, Pages 7271-7278

  Sivasubramanian, Maharajan ^a   Thambi, Thavasyappan ^b   Deepagan, V G ^b   Saravanakumar, Gurusamy ^b   Ko, Hyewon ^b   Kang, Young Mo ^c   Park, Jae Hyung ^b  

^a Kyung Hee University   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c Kyungpook National University School of Medicine   (South Korea)

Author keywords

Carboxymethyl dextran; Cyclodextrin; Doxorubicin; Nanoparticles

Indexed keywords

ANTICANCER DRUG; CARBOXYMETHYL DEXTRAN; DOXORUBICIN; FLUORESCENCE SIGNALS; INCLUSION COMPLEX; INTRACELLULAR UPTAKE; LOADING EFFICIENCY; SELF ASSEMBLED NANOPARTICLES;

BIOCOMPATIBILITY; CELLS; CYCLODEXTRINS; EMULSIFICATION; FLUORESCENCE; HYDROGEN BONDS;

NANOPARTICLES;

ANTINEOPLASTIC AGENT; DOXORUBICIN; NANOCAPSULE;

ANIMAL; CARCINOMA, SQUAMOUS CELL; CELL SURVIVAL; CHEMISTRY; DIFFUSION; DRUG EFFECTS; MOUSE; PARTICLE SIZE; PATHOLOGY; TREATMENT OUTCOME; TUMOR CELL LINE; ULTRASTRUCTURE; ARTICLE; DRUG EFFECT; SQUAMOUS CELL CARCINOMA;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL SURVIVAL; DIFFUSION; DOXORUBICIN; MICE; NANOCAPSULES; PARTICLE SIZE; TREATMENT OUTCOME;

EID: 84891504943     PISSN: 15334880     EISSN: 15334899     Source Type: Journal    
DOI: 10.1166/jnn.2013.8091     Document Type: Article

References (37)

1. S. K. Carter, J. Natl. Cancer I. 55, 1265 (1975).
2. P. K. Singal and N. Iliskovic, New. Engl. J. Med. 339, 900 (1998).
3. X. X. Huang, C. L. Zhou, H. Wang, C. Chen, S. Q. Yu, Q. Xu, Y. Y. Zhu, and Y. Ren, AAPS. Pharm. Sci. Tech. 12, 665 (2011).
4. L. Varticovski, Z. R. Lu, K. Mitchell, I. de Aos, and J. Kopeèek, J. Controlled Release 74, 275 (2001).
5. N. Larson, A. Ray, A. Malugin, D. B. Pike, and H. Ghandehari, Pharm. Res. 27, 2683 (2010).
6. G. Zhai, J. Wu, B. Yu, C. Guo, X. Yang, and R. T. Lee, J. Nanosci. Nanotechnol. 10, 5129 (2010).
7. W. G. Pitt, G. A. Husseini, B. L. Roeder, D. J. Dickinson, D. R. Warden, J. M. Hartley, and P. W. Jones, J. Nanosci. Nanotechnol. 11, 1866 (2011).
8. P. A. Barbugli, M. P. Siqueira-Moura, E. M. Espreafico, and A. C. Tedesco, J. Nanosci. Nanotechnol. 10, 569 (2010).
9. H. Zhang, H. Xia, J. Wang, and Y. Li, J. Controlled Release 139, 31 (2009).
10. M. Talelli, C. J. F. Rijcken, S. Oliveira, R. van der Meel, P. M. van Bergen en Henegouwen, T. Lammers, C. F. van Nostrum, G. Storm, and W. E. Hennik, J. Controlled Release 153, 93 (2011).
11. T. Thambi, V. G. Deepagan, H. Ko, D. S. Lee, and J. H. Park, J. Mater. Chem. 22, 22028 (2012).
12. K. K. Upadhyay, A. K. Mishra, K. Chuttani, A. Kaul, C. Schatz, J. F. Le Meins, A. Misra, and S. Lecommandoux, Nanomedicine 8, 71 (2012).
13. T. Loftsson and M. E. Brewster, J. Pharm. Sci. 85, 1017 (1996).
14. R. A. Rajewski and V. J. Stella, J. Pharm. Sci. 85, 1142 (1996).
15. Y. Liu, G. S. Chen, L. Li, H. Y. Zhang, D. X. Cao, and Y. J. Yuan, J. Med. Chem. 46, 4634 (2003).
16. O. Bekers, J. H. Beijnen, M. Otagiri, A. Bult, and W. J. M. Underberg, J. Pharmaceut. Biomed. 8, 671 (1990).
17. A. Harada and M. Kamachi, Macromolecules 23, 2821 (1990).
18. A. Harada, Coordin. Chem. Rev. 148, 115 (1996).
19. W. Q. Tong, J. L. Lach, T. F. Chin, and J. K. Guillory, Pharm. Res. 8, 951 (1991).
20. Y. Liu, G. S. Chen, Y. Chen, D. X. Cao, Z. Q. Ge, and Y. J. Yuan, Bioorg. Med. Chem. 12, 5767 (2004).
21. M. Sivasubramanian, Y. J. Kim, S. Y. Chae, S. Son, D. J. Jo, K. C. Lee, C. K. Yoo, and J. H. Park, J. Biomater. Sci. Polym. Ed. 23, 1995 (2012).
22. M. E. Davis and M. E. Brewster, Nat. Rev. Drug. Discov. 3, 1023 (2004).
23. V. Monnaert, D. Betbeder, L. Fenart, H. Bricout, A. M. Lenfant, C. Landry, R. Cecchelli, E. Monflier, and S. Tilloy, J. Pharmacol. Exp. Ther. 311, 1115 (2004).
24. Y. Hagiwara, H. Arima, F. Hirayama, and K. Uekama, J. Incl. Phenom. Macro. 56, 65 (2006).
25. H. Arima, Y. Hagiwara, F. Hirayama, and K. Uekama, J. Drug Target 14, 225 (2006).
26. J. Cheng, K. T. Khin, G. S. Jensen, A. Liu, and M. E. Davis, Bioconjugate. Chem. 14, 1007 (2003).
27. A. Charlot, A. Heyraud, P. Guenot, M. Rinaudo, and R. Auzély-Velty, Biomacromolecules 7, 907 (2006).
28. Y. Matsumura and H. Maeda, Cancer Res. 46, 6387 (1986).
29. S. K. Hobbs, W. L. Monsky, F. Yuan, W. G. Roberts, L. Griffith, V. P. Torchilin, and R. K. Jain, Proc. Natl. Acad. Sci. USA 95, 4607 (1998).
30. K. Y. Choi, K. H. Min, J. H. Na, K. Choi, K. Kim, J. H. Park, I. C. Kwon, and S. Y. Jeong, J. Mater. Chem. 19, 4102 (2009).
31. K. Miyajima, T. Mukai, M. Nakagaki, M. Otagiri, and K. Uekama, Bull. Chem. Soc. Jpn. 59, 643 (1986).
32. M. Messner, S. V. Kurkov, P. Jansook, and T. Loftsson, Int. J. Pharm. 387, 199 (2010).
33. W. Sajomsang, P. Gonil, U. R. Ruktanonchai, N. Pimpha, I. Sramala, O. Nuchuchua, S. Saesoo, S. Chaleawlert-umpon, and S. Puttipipatkhachorn, Int. J. Bio. Macromol. 48, 589 (2011).
34. O. Häusler and C. C. Müller-Goymann, Starch. 45, 183 (1993).
35. L. Szente, J. Szejtli, and G. L. Kis, J. Pharm. Sci. 87, 778 (1998).
36. J. Zhang, K. Ellsworth, and P. X. Ma, J. Controlled Release 145, 116 (2010).
37. J. Zhang and P. X. Ma, Angew. Chem. Int. Ed. 48, 964 (2009).